Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.36
- Piotroski Score 6.00
- Grade Overweight
- Symbol (ATR)
- Company AptarGroup, Inc.
- Price $175.82
- Changes Percentage (0.64%)
- Change $1.11
- Day Low $174.49
- Day High $177.84
- Year High $177.84
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
- Last Earnings 10/10/2024
- Ex-Dividend for 5/16 Dividend 10/24/2024
- Dividend Payable 11/14/2024
- Today N/A
- Next Earnings (Estimated) 02/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $125.00
- High Stock Price Target $215.00
- Low Stock Price Target $45.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.66
- Trailing P/E Ratio 31.23
- Forward P/E Ratio 31.23
- P/E Growth 31.23
- Net Income $284.49 M
Income Statement
Quarterly
Annual
Latest News of ATR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
OrthoPediatrics Corp (KIDS) Q3 2024 Earnings Call Highlights: Record Revenue and Raised ...
T&D performance in Q3 slowed due to the absence of a one-time order from South America. Organic growth, excluding the Boston O&P acquisition, was strong. 7D placements at larger institutions are expec...
By Yahoo! Finance | 15 hours ago -
Fears grow that woman arrested for undressing in Iran could be tortured in psychiatric unit
Rights groups raise alarm over protesters and political prisoners being drugged, tortured, and beaten in Iranian state-run institutions. Young woman arrested for protesting faces risk of torture in ps...
By The Guardian | 15 hours ago -
Bears try to regroup from back-to-back losses when they host Patriots
Bears defeated Patriots 33-14 in their last meeting. Patriots lost to Tennessee, Bears lost to Arizona. QB Drake Maye dazzled but also threw two interceptions. QB Caleb Williams has cooled off recentl...
By AP NEWS | 1 day ago
